Search results for: 'biologicals forecast'

The $953 million APAC video conferencing devices market is undergoing fundamental shifts due to massive work and workplace transformation. In 2023, most customers took a measured approach to video-enabling meeting rooms due to budget rationalization and reassessment of investment priorities in the post-pandemic workplace. Adverse macroeconomic cond...

10 Jan 2018  |  Asia Pacific  |  Market Research

APAC Biosimilar Market, Forecast 2025

Patent Expiries, Defined Regulatory Pathways, and Escalating Healthcare Costs to Boost Growth

Infographics

×

Key Issues Addressed Key Benefits

Biosimilars is a massive opportunity; regardless of a slow start, the market will eventually be a huge business. As per Frost & Sullivan’s estimate, biologic drugs worth $70–$80 billion will lose exclusivity in the next 5 years globally and APAC’s contribution would be more than 20%. Countries in the region, such as India, China, and South Korea, o...

The growing use of digital payments in Asia-Pacific (APAC) paves the way for innovation and new use cases that address user pain points payment solutions, such as self-checkout, enhance customer experience while software point-of-sale (softPOS) accelerates the merchant onboarding process. The APAC market will become more aware of the benefits of ne...

In 2018, the retail IoT market in Asia-Pacific generated a revenue of $1.72 billion, and it is anticipated to grow at a compound annual growth rate of 24.8Percentage from 2018 to 2025 to reach $10.00 billion in 2025. This growth insight discusses market size in terms of spending across key application areas such as WiFi-based analytics, video and o...

The APAC Agriculture IoT market stood at $0.12 billion in 2018 and is anticipated to grow at a compound annual growth rate of 27.4Percentage between 2018 to 2025 to reach $0.65 billion by 2025. The study has calculated the spending across key application areas comprising crop surveying and condition monitoring, smart irrigation systems, precision p...

This Frost & Sullivan report examines the automotive industry in China, with a focus on passenger vehicles (PVs). The segments covered include vans, sports utility vehicles (SUVs), multipurpose vehicles (MPVs), and cross vehicles. The study also assesses China’s electric vehicle (EV) sector, including the charging and battery-swapping infrastructur...

With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...

The Asia-Pacific (APAC) water sector is entering a decisive transition phase, where resilience, efficiency, and regulatory compliance are becoming as critical as capacity expansion. As climate volatility, industrial complexity, and urban density intensify across the region, water and wastewater systems are being reshaped by circularity principles, ...

In this analysis, Frost & Sullivan examines the commercial truck industry in China, focusing on the light, medium, and heavy-duty commercial truck segments. Commercial trucks are crucial in various areas in China, such as manufacturing, agriculture, forestry, mining, construction, transportation and warehousing, wholesale, and retail, contributing ...